The new procedure shortens wait times from three days and could help reduce the spread of superbug bacteria.
The discovery of antibiotics in the early part of the 20th century changed modern medicine. Simple infections that previously killed people became easy to treat. Antibiotics’ ability to stave off infections made possible routine surgeries, organ transplants, and chemotherapy for the treatment of cancer.
But because of overuse and misuse, antibiotics are losing their effectiveness. Many species of bacteria have evolved resistance to commonly used antibiotics and multidrug-resistant bacteria—so-called superbugs—have emerged, plaguing hospitals and nursing homes. Last month, the World Health Organization issued a dire warning: The world is running out of antibiotics.
A new test developed at Caltech that identifies antibiotic-resistant bacteria in as little as 30 minutes could help turn the tide by allowing medical professionals to better choose which antibiotics to treat an infection with. A paper describing the method appears in the October 4 issue of Science Translational Medicine.
When doctors treat patients with bacterial infections, they often skip over first-line antibiotics like methicillin or amoxicillin—drugs that bacteria are more likely to be resistant to—and go straight for stronger second-line antibiotics, like ciprofloxacin. This practice increases the chance that the treatment will be effective, but it is not ideal. That’s because the increased use of second-line antibiotics makes it more likely that bacteria also will become resistant to these stronger drugs.
“Right now, we’re overprescribing, so we’re seeing resistance much sooner than we have to for a lot of the antibiotics that we would otherwise want to preserve for more serious situations,” says Nathan Schoepp, a Caltech graduate student and co-author of the study.
The problem is that there has not been a quick and easy way for a doctor to know if their patient’s infection is resistant to particular antibiotics. To find out, the doctor would have to send a sample to a testing lab, and wait two to three days for an answer.
“Therapies are driven by guidelines developed by organizations like the World Health Organization or the Centers for Disease Control and Prevention without knowing what the patient actually has, because the tests are so slow,” says Rustem Ismagilov, Caltech’s Ethel Wilson Bowles and Robert Bowles Professor of Chemistry and Chemical Engineering and director of the Jacobs Institute for Molecular Engineering for Medicine. “We can change the world with a rapid test like this. We can change the way antibiotics are prescribed.”
Ismagilov, Schoepp, Caltech graduate student Travis Schlappi, who is also a co-author, and their fellow researchers aimed to develop a test that could be completed during a single visit to the doctor’s office. They focused on one of the most common types of infections in humans, urinary tract infections (UTIs), which 50 percent of women contract during their lifetimes. UTIs result in eight million doctor visits and one million ER visits each year in the United States alone.
The researchers’ new test works like this: A sample of urine (which may contain bacteria) collected from a patient with a UTI is divided into two parts. One part is exposed to an antibiotic for 15 minutes, while the other part incubates without antibiotics. The bacteria from each sample then are broken open (lysed) to release their cellular contents, which are run through a process that combines a detection chemistry technique called digital real-time loop-mediated isothermal amplification, or dLAMP, with a device called a SlipChip (SlipChips are a previous invention of Ismagilov and his Caltech colleagues). This combination replicates specific DNA markers so they can be imaged and individually counted as discrete fluorescent spots appearing on the chip.
The test operates on the principle that typical bacteria will replicate their DNA (in preparation for cellular division) less well in an antibiotic solution, resulting in the presence of fewer DNA markers. However, if the bacteria are resistant to the antibiotic, their DNA replication will not be hampered and the test will reveal similar numbers of DNA markers in both the treated and untreated solutions.
When used on 54 samples of urine from patients with UTIs caused by the bacteria Escherischia coli, the test results had a 95 percent match with those obtained using the standard two-day test, which is considered the gold standard for accuracy.
Ismagilov and Schoepp plan to begin running the test on other types of infectious bacteria to see how well it performs. They also hope to tweak the testing procedures to work with blood samples. Blood infections are more difficult to test because the bacteria are present in much lower numbers than they are in urine, but such a test could help reduce mortality from blood-borne infections, which can turn fatal if not treated quickly.
The Latest on: Antibiotic-resistant bacteria
- Deaths from antibiotic-resistant infections on the rise, study sayson November 14, 2019 at 4:21 pm
The CDC said in its report that, on average, someone in the United States gets an antibiotic-resistant infection every 11 seconds and that someone dies every 15 minutes. When including bacteria like ...
- CDC: The number of Americans dying from antibiotic-resistant "superbugs" vastly underestimatedon November 14, 2019 at 4:09 pm
“In some outbreaks, reported mortality has approached 60 percent.” Clostridioides difficile is an antibiotic-resistant bacteria that can cause diarrhea. It often occurs while someone is taking ...
- Antibiotic-Resistant Superbugs Infect Nearly 3 Million Americans Each Year, Kill More than 35,000on November 14, 2019 at 11:27 am
A new CDC report has both good and bad news about antibiotic-resistant superbugs.
- Antibiotic-resistant infections are deadlier than before. Here are 5 things to knowon November 14, 2019 at 10:40 am
Antibiotic-resistant infections are deadlier than expected, the CDC report found. Fungi and bacteria that are antibiotic resistant cause 2.8 million infections and 35,000 deaths in the United States ...
- Antibiotic-resistant bacteria a deadly threat 'that is not going away,' CDC sayson November 14, 2019 at 9:51 am
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and at least 35,900 deaths every year in the United States, according to a new U.S. Centers for Disease Control and ...
- The Threat From Antibiotic-Resistant Germs Gets Scarieron November 14, 2019 at 9:46 am
More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result, according to the latest report from the U.S. Centers for ...
- The 'post-antibiotic era' is here: Drug-resistant superbugs sicken 2.8M and kill 35K each yearon November 14, 2019 at 7:12 am
Some germs have outpaced us':‘Nightmare’ bacteria, resistant to almost every drug, stalk U.S. hospitals The report establishes a new baseline of infections and deaths from antibiotic-resistant germs ...
- Daily on Healthcare, presented by SBEC: Antibiotic-resistant infections are killing far more people than realizedon November 14, 2019 at 7:01 am
SUBSCRIBE NOW: Just $1.00 an issue! ABOUT 35,000 AMERICANS DIE ANNUALLY OF DRUG-RESISTANT INFECTIONS: Antibiotic-resistant bacteria cause about 2.8 million infections per year and about 35,000 deaths ...
- Twice as many killed by antibiotic-resistant bacteria than thought, feds say, but infections overall are fallingon November 13, 2019 at 11:37 pm
published in the first comprehensive estimate by the U.S. Centers of Disease Control and Prevention of antibiotic-resistant infections since its last report in 2013, show that nearly 3 million people ...
- Antibiotic-resistant infections killing twice as many Americans as once thoughton November 13, 2019 at 4:31 pm
(Reuters) - Nearly twice as many people are dying in the United States from antibiotic-resistant infections than previously believed ... Global health officials have repeatedly warned about the rise ...
via Google News and Bing News